On May 28, 2024, the Turkish Medicines and Medical Devices Agency (Agency) took a significant step in regulating the healthcare industry by unveiling the draft Regulation on Promotional Activities of Medicinal Products for Human Use and Foods for Special Medical Purposes (Draft). This comprehensive Draft aims to address various aspects of promotional activities, ensuring that they are conducted in a manner that upholds scientific integrity and prioritizes patient safety.
Wardynski & Partners Advises IVC Evidensia on Veterinary Clinics Acquisition in Warsaw
Wardynski & Partners has advised IVC Evidensia Poland on the acquisition of two veterinary clinics in Warsaw.
Cobalt Advises Practica Venture Capital on Exit from MedDream
Cobalt has advised Practica Venture Capital on its exit from MedDream. Ellex reportedly advised the unidentified buyers.
Dorda Advises P95 on Takeover of Assign DMB
Dorda, working with McDermott Will & Emery and Quinz, has successfully advised P95 on its acquisition of the Austrian CRO Assign DMB.
Slow to Address Romania's Healthcare Ills: A Buzz Interview with Dominic Morega of Tuca Zbarcea & Asociatii
With a growing economy but significant structural deficits, Romania’s healthcare system struggles with underfunding, slow approval processes, and high taxes, making access to new therapies a slow and challenging endeavor, according to Tuca Zbarcea & Asociatii Managing Associate and Head of Pharma and Medical Devices Dominic Morega.
Dentons Advised AniCura on Acquisition of VetCare Group
Dentons has advised AniCura on the acquisition of VetCare Group in Slovakia and the Czech Republic from HardWood Investments. Acres reportedly advised HardWood Investments.
Schoenherr and Gide Advise on Enterprise Investors Fund IX Investment in Scan Lab
Schoenherr has advised mBank on financing the acquisition of Scan Lab by Enterprise Investors Fund IX. Gide advised Enterprise Investors.